AstraZeneca"s CEO David Brennan has estimated that the company can deliver 40 million doses in sprayers by March 2010 and if it can find an alternative to the sprayers which administers the vaccine through the nose and are in short supply the company hopes to increase the number of doses to 200 million. This comes as the company posted a 5.6 percent raise in second-quarter profit. Brennan added the option of delivering the vaccine in drops may be used.
저작권자 © 메디칼업저버 무단전재 및 재배포 금지